by: ASRM Office of Public Affairs
Published in ASRM Bulletin Volume 15, Number 2
The U.S. Supreme Court has declined to hear an appeal of Sherley v. Sebelius, a case involving federal funding of human embryonic stem research. Below is a statement issued today by the Coalition for the Advancement of Medical Research, of which ASRM is a founding member.
CAMR Statement: Supreme Court Denies Certiorari For Sherley v. Sebelius
Coalition for the Advancement of Medical Research (CAMR) WASHINGTON, D.C.
JANUARY 7, 2013
The following statement may be attributed to Amy Comstock Rick, CAMR president:
“What a great day for science and for the 100 million Americans who live with debilitating diseases and conditions for which human embryonic stem cell research provides hope.
The Supreme Court’s denial of certiorari for Sherley v. Sebelius brings an end to this long, unnecessary litigation. This is a victory for scientists, patients, and the entire biomedical research community. Science can now continue to move forward, knowing the threat to promising research and funding has been eliminated.
The National Institutes of Health (NIH) currently has 198 embryonic stem cell lines on its registry, up from just 21 in 2009 when the NIH implemented President Obama’s Executive Order expanding federal funding for ethical human embryonic stem cell research.
CAMR filed an amicus brief in the District Court and Court of Appeals arguments.
For more than a decade, CAMR has worked to level the playing field for human embryonic stem cell research so that it had equal and fair access to funding and NIH oversight, and we are honored to have played a role in today’s Supreme Court decision that accomplished that very goal.”
The Coalition for the Advancement of Medical Research (CAMR) is the nation's leading bipartisan pro-cures coalition. Comprised of 100 nationally recognized patient organizations, universities, scientific societies, and foundations, CAMR’s advocacy and education outreach focuses on research toward developing better treatments and cures for individuals with life-threatening illnesses and disorders.
The ASRM Bulletin is published by ASRM's Office of Public Affairs to inform Society members of important recent developments. Republication or any other use of the contents of the Bulletin without permission is prohibited. To request permission to quote or excerpt material from the Bulletin, contact Sean Tipton at email@example.com.